Inbec是一种什么药物呢?
What kind of medicine is Suimeikai? Suimeikan Inbec is suitable for the treatment of adults and adolescents over 12 years old (with a weight of at least 40kg) infected with human immunodeficiency virus (HIV). In 2016, GSK announced the launch of the integrase DTG Suimeikan Inbec in China. The drug Suimeikan Inbec has the advantages of small drug dosage, resistance to drug resistance, and low probability of drug side effects. This time Suimeikan Inbec uses DTG, an integrase inhibitor, as the core drug, coupled with a treatment plan of two backbone drugs, abacavir and lamivudine, and made a single-tablet treatment for promotion, making the core drug a great progress in HAART treatment. In addition, Suimeikai Inbec treatment can significantly reduce the medication burden of AIDS patients, thereby improving patients' medication compliance and effectively improving the patients' quality of life and work.
Judging from a large number of clinical trial data, DTG has a low discontinuation rate due to adverse drug reactions (ADR) or virological failure, which are 5.8% and 0.5% respectively. The ADR drops significantly after one year of taking the drug. The most common adverse reactions are gastrointestinal dysfunction, mental disorders and neurological disorders, but the adverse reaction rates are less than 1.5%. From the comparison with patients who failed the first-line treatment of the other two integrase inhibitors RAL (Ascent) and EVG (elvitegravir), Inbec (Inbec) has significantly fewer resistance mutation sites than the other two drugs, making it less likely to develop resistance. Inbec has been approved in more than 100 countries and recommended by many authoritative academic institutions in Europe and the United States as a first-line treatment drug for newly treated AIDS patients.
Recommended dosage: Adults and adolescents (weighing at least 40kg). For adults and adolescents, the recommended dosage of Trimax Inbec is one tablet, once daily. Adults or adolescents who weigh less than 40kg should not be given Trimax Inbec as Trimax Inbec is a fixed dose tablet and the dose cannot be reduced.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)